The atheroprotective effect of 17β-estradiol depends on complex interactions in adaptive immunity

American Journal of Pathology

Volumn 167, Issue 1, 2005, Pages 267-274

  Elhage, Rima ^a   Gourdy, Pierre ^a   Jawien, Jacek ^c,d   Brouchet, Laurent ^a   Castano, Caroine ^a   Fievet, Catherine ^b   Hansson, Göran K ^c   Arnal, Jean François ^a   Bayard, Francis ^a  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c KAROLINSKA INSTITUTE   (Sweden)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ESTRADIOL; LOW DENSITY LIPOPROTEIN RECEPTOR; DNA BINDING PROTEIN; RAG2 PROTEIN, MOUSE; V(D)J RECOMBINATION ACTIVATING PROTEIN 2;

ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; AORTA; ARTERIOSCLEROSIS; BONE MARROW TRANSPLANTATION; GENETICS; HEART; HEART MUSCLE; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MOUSE MUTANT; OVARIECTOMY; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ANIMALS; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BONE MARROW TRANSPLANTATION; DNA-BINDING PROTEINS; ESTRADIOL; FEMALE; HEART; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCARDIUM; OVARIECTOMY; RECEPTORS, LDL; T-LYMPHOCYTE SUBSETS;

EID: 21244503986     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62971-9     Document Type: Article

References (45)

1. Waters DD, Gordon D, Rossouw JE, Cannon III RO, Collins P, Herrington DM, Hsia J, Langer R, Mosca L, Ouyang P, Sopko G, Stefanick ML: Women's ischemic syndrome evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute Workshop: October 2-4, 2002: section 4: lessons from hormone replacement trials. Circulation 2004, 109:e53-e55
2. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998, 280:605-613
3. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333
4. Arnal JF, Gourdy P, Elhage R, Garmy-Susini B, Delmas E, Brauchet L, Castano C, Barreira Y, Couloumiers JC, Prats H, Prats AC, Bayard F: Estrogens and atherosclerosis. Eur J Endocrinol 2004, 150:113-117
5. Hodgin JB, Maeda N: Minireview: estrogen and mouse models of atherosclerosis. Endocrinology 2002, 143:4495-4501
6. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-125
7. Hansson GK, Libby P, Schonbeck U, Van ZQ: Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002, 91:281-291
8. Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, Witztum JL: Innate and acquired immunity in atherogenesis. Nat Med 2002, 8:1218-1226
9. -/- mice. Decreasing density with disease progression. Arterioscler Thromb Vasc Biol 1996, 16:1013-1018
10. Song L, Leung C, Schindler C: Lymphocytes are important in early atherosclerosis. J Clin Invest 2001, 108:251-259
11. Reardon CA, Blachowicz L, White T, Cabana V, Wang Y, Lukens J, Bluestone J, Getz GS: Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2001, 21:1011-1016
12. Elhage R, Gourdy P, Brauchet L, Jawien J, Fouque M-J, Fiévet C, Huc X, Barreira Y, Couloumiers J-C, Arnal J-F, Bayard F: Deleting TCRaβ+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. Am J Pathol 2004, 165:2013-2019
13. Zhou X, Nicoletti A, Elhage R, Hansson GK: Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000, 102:2919-2922
14. Elhage R, Clamens S, Reardon-Alulis C, Getz GS, Fievet C, Maret A, Arnal JF, Bayard F: Loss of atheroprotective effect of estradiol in immunodeficient mice. Endocrinology 2000, 141:462-465
15. Elhage R, Arnal JF, Pierragi M-T, Duverger N, Fiévet C, Faye JC, Bayard F: Estradiol-17β prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscl Thromb Vasc Biol 1997, 17: 2679-2684
16. Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK: Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 1994, 93:1885-1893
17. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, Alt FW: RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867
18. Kitamura D, Roes J, Kuhn R, Rajewsky K: A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991, 350:423-426
19. Duez H, Chao YS, Hernandez M, Torpier G, Poulain P, Mundt S, Mallat Z, Teissier E, Burton CA, Tedgui A, Fruchart JC, Fievet C, Wright SD, Staels B: Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice. J Biol Chem 2002, 277:48051-48057
20. Marsh MM, Walker VR, Curtiss LK, Banka CL: Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J Lipid Res 1999, 40:893-900
21. Bourassa P-A, Milos PM, Gaynor BJ, Breslow JL, Aiello RJ: Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 1996, 93:10022-10027
22. Shedlock DJ, Whitmire JK, Tan J, MacDonald AS, Ahmed R, Shen H: Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection. J Immunol 2003, 170:2053-2063
23. Shevach EM, McHugh RS, Piccirillo CA, Thornton AM: Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev 2001, 182:58-67
24. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK: Type 1 T regulatory cells. Immunol Rev 2001, 182:68-79
25. Matejuk A, Bakke AC, Hopke C, Dwyer J, Vandenbark AA, Offner H: Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis. J Neurosci Res 2004, 77:119-126
26. Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler SF, Offner H: Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol 2004, 173:2227-2230
27. Caligiuri G, Nicoietti A, Poirier B, Hansson GK: Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002, 109:745-753
28. Verthelyi DI, Ahmed SA: Estrogen increases the number of plasma cells and enhances their autoantibody production in nonautoimmune C57BL/6 mice. Cell Immunol 1998, 189:125-134
29. Horkko S, Bird DA, Miller E, Itabe H, Leitinger N, Subbanagounder G, Berliner JA, Friedman P, Dennis EA, Curtiss LK, Palinski W, Witztum JL: Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 1999, 103:117-128
30. Major AS, Fazio S, Linton MF: B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 2002, 22:1892-1898
31. Holm P, Korsgaard N, Shalmi M, Andersen HL, Hougaard P, Skouby SO, Stender S: Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits. J Clin Invest 1997, 100:821-828
32. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB: Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 1990, 10:1051-1057
33. Medina KL, Garrett KP, Thompson LF, Rossi MI, Payne KJ, Kincade PW: Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat Immunol 2001, 2:718-724
34. Okasha SA, Ryu S, Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS: Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus. Toxicology 2001, 163:49-62
35. -/- mice. J Clin Invest 2001, 107:333-340
36. Shi W, Haberland ME, Jien ML, Shih DM, Lusis AJ: Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation 2000, 102:75-81
37. Shi W, Wang NJ, Shih DM, Sun VZ, Wang X, Lusis AJ: Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circ Res 2000, 86:1078-1084
38. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C: IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 1997, 99:2752-2761
39. Lee TS, Yen HC, Pan CC, Chau LY: The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 1999, 19:734-742
40. Elhage R, Jawien J, Rudling M, Ljunggren HG, Takeda K, Akira S, Bayard F, Hansson GK: Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 2003, 59:234-240
41. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A: Protective role of interleukin-10 in atherosclerosis. Circ Res 1999, 85:e17-e24
42. Robertson AKL, Rudling M, Zhou X, Gorelik L, Flavell RA, Hansson GK: Disruption of TGF-(beta) signaling in T cells accelerates atherosclerosis. J Clin Invest 2003, 112:1342-1350
43. Cenci S, Toraldo G, Weitzmann MN, Roggia C, Gao Y, Qian WP, Sierra O, Pacifici R: Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci USA 2003, 100:10405-10410
44. Maret A, Coudert JD, Garidou L, Foucras G, Gourdy P, Krust A, Dupont S, Chambon P, Druet P, Bayard F, Query JC: Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur J Immunol 2003, 33:512-521
45. Gourdy P, Araujo LM, Zhu R, Garmy-Susini B, Diem S, Laurell H, Leite-De-Moraes M, Dy M, Arnal JF, Bayard F, Herbelin A. Relevance of sexual dimorphism to regulatory T cells: estradiol promotes IFN-γ production by invariant natural killer T cells. Blood 2005, 105: 2415-2420